| 1 |
郎景和. 对子宫内膜异位症认识的历史、现状与发展 [J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
|
| 2 |
李鳌, 孙宏伟, 崔彦. 代谢组学应用与研究进展 [J]. 医学研究杂志, 2020, 49(1): 168-171.
|
| 3 |
朱嘉, 方祝元. 代谢组学与中医"证"的相关性 [J]. 现代中西医结合杂志, 2009, 18(8): 938-941.
|
| 4 |
郭荔. 子宫内膜异位症患者血清代谢组学分析 [D]. 大连: 大连医科大学, 2019.
|
| 5 |
宋景艳. 子宫内膜异位症肾虚血瘀证代谢物组初筛及其与卵母细胞质量之间的关系 [D].济南: 山东中医药大学, 2017.
|
| 6 |
Vouk K, Hevir N, Ribić-Pucelj M, et al. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis [J]. Hum Reprod, 2012, 27(10): 2955-2965.
|
| 7 |
Lee YH, Tan CW, Venkatratnam A, et al. Dysregulated sphingolipid metabolism in endometriosis [J]. J Clin Endocrinol Metab, 2014 Oct;99(10):E1913-21.
|
| 8 |
Karaer A, Tuncay G, Mumcu A, et al. Metabolomics analysis of follicular fluid in women with ovarian endometriosis undergoing in vitro fertilization [J]. Syst Biol Reprod Med, 2019, 65(1): 39-47.
|
| 9 |
Ocal P, Ersoylu B, Cepni I, et al. The association between homocysteine in the follicular fluid with embryo quality and pregnancy rate in assisted reproductive techniques [J]. J Assist Reprod Genet, 2012, 29(4): 299-304.
|
| 10 |
Pocate-Cheriet K, Santulli P, Kateb F, et al. The follicular fluid metabolome differs according to the endometriosis phenotype [J]. Reprod Biomed Online, 2020, 41(6): 1023-1037.
|
| 11 |
Dutta M, Joshi M, Srivastava S, et al. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis [J]. Mol Biosyst, 2012, 8(12): 3281-3287.
|
| 12 |
Karanjgaokar VC, Murphy DJ, Samra JS, et al. Malignant transformation of residual endometriosis after hysterectomy: a case series [J]. Fertil Steril, 2009, 92(6): 2037.e19-21.
|
| 13 |
Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis [J]. Hum Reprod, 2003, 18(10): 2052-2057.
|
| 14 |
Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, et al. Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients [J]. Fertil Steril, 2016, 106(7): 1733-1741.
|
| 15 |
Jana SK, Dutta M, Joshi M, et al. 1H NMR based targeted metabolite profiling for understanding the complex relationship connecting oxidative stress with endometriosis [J]. Biomed Res Int, 2013, 2013: 329058.
|
| 16 |
Dutta M, Singh B, Joshi M, et al. Metabolomics reveals perturbations in endometrium and serum of minimal and mild endometriosis [J]. Sci Rep, 2018, 8(1): 6466.
|
| 17 |
Ghazi N, Arjmand M, Akbari Z, et al. (1)H NMR- based metabolomics approaches as non-invasive tools for diagnosis of endometriosis [J]. Int J Reprod Biomed, 2016, 14(1): 1-8.
|
| 18 |
Maignien C, Santulli P, Kateb F, et al. Endometriosis phenotypes are associated with specific serum metabolic profiles determined by proton-nuclear magnetic resonance [J]. Reprod Biomed Online, 2020, 41(4): 640-652.
|
| 19 |
Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, et al. Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis [J]. Fertil Steril, 2015, 104(5): 1202-1209.
|
| 20 |
Vouk K, Ribič-Pucelj M, Adamski J, et al. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients [J]. J Steroid Biochem Mol Biol, 2016, 159: 60-69.
|
| 21 |
Li J, Guan L, Zhang H, et al. Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages [J]. Reprod Biol Endocrinol, 2018, 16(1): 42.
|
| 22 |
Chen JQ, Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells [J]. Biochim Biophys Acta, 2012, 1826(2): 370-384.
|